POULVAC BURSA F

Rapid immunity development against IBD

Live vaccine against infectious bursal disease (Gumboro disease)
Provides reliable protection for commercial poultry against immunosuppression
Effectively administered via drinking water from the first days of life

Available as

Lyophilisate

For use with

Poultry

Strength

IBD virus

How it is supplied

Vial

Learn more

Drug description

Live Vaccine POULVAC BURSA F

Infectious bursal disease (IBD / Gumboro) is one of the most serious threats in poultry farming. Zoetis developed live dry vaccine POULVAC BURSA F — attenuated IBD virus (strain V877) grown on clean SPF chicken embryos.

Key advantage: high invasiveness. Protection against clinical and subclinical forms. Promotes quick bursa of Fabricius recovery.

Dosage: single drinking water administration. Active immunity within 14 days, lasting at least 3 months.

Start cooperation with industry leaders